Follow
Joachim Morrens
Joachim Morrens
Verified email at its.jnj.com
Title
Cited by
Cited by
Year
Glial cells in adult neurogenesis
J Morrens, W Van Den Broeck, G Kempermann
Glia 60 (2), 159-174, 2012
1902012
Cue-evoked dopamine promotes conditioned responding during learning
J Morrens, Ç Aydin, AJ van Rensburg, JE Rabell, S Haesler
Neuron 106 (1), 142-153. e7, 2020
992020
Real-world evidence from a European cohort study of patients with treatment resistant depression: treatment patterns and clinical outcomes
K Heerlein, G Perugi, C Otte, T Frodl, G Degraeve, W Hagedoorn, ...
Journal of Affective Disorders 290, 334-344, 2021
472021
Real-world evidence from a European cohort study of patients with treatment resistant depression: baseline patient characteristics
K Heerlein, AH Young, C Otte, T Frodl, G Degraeve, W Hagedoorn, ...
Journal of Affective Disorders 283, 115-122, 2021
322021
Real-world evidence from a European cohort study of patients with treatment resistant depression: healthcare resource utilization
K Heerlein, S De Giorgi, G Degraeve, T Frodl, W Hagedoorn, ...
Journal of Affective Disorders 298, 442-450, 2022
162022
Use of Clinical Global Impressions-Severity (CGI-S) to assess response to antidepressant treatment in patients with treatment-resistant depression
J Morrens, M Mathews, V Popova, S Borentain, B Rive, BGM Moro, ...
Neuropsychiatric Disease and Treatment 18, 1127, 2022
72022
Dopamine neurons coding prediction errors in reward space, but not in aversive space: a matter of location?
J Morrens
Journal of Neurophysiology 112 (5), 1021-1024, 2014
62014
Simultaneous measurement of glomerular filtration rate, effective renal plasma flow and tubular secretion in different poultry species by single intravenous bolus of iohexol …
L Stroobant, S Croubels, L Dhondt, J Millecam, S De Baere, E Gasthuys, ...
Animals 10 (6), 1027, 2020
52020
Clinical features and outcomes of 124 Italian patients with treatment resistant depression: a real-world, prospective study
G Perugi, P Calò, S De Filippis, G Rosso, A Vita, M Adami, G Ascione, ...
Frontiers in Psychiatry 12, 769693, 2021
42021
Development of an in vivo lipopolysaccharide inflammation model to study the pharmacodynamics of COX-2 inhibitors celecoxib, mavacoxib, and meloxicam in cockatiels (Nymphicus …
E Gasthuys, R Houben, R Haesendonck, S De Baere, SU Sys, J Morrens, ...
Journal of avian medicine and surgery 33 (4), 349-360, 2019
42019
ICEBERG study: an indirect adjusted comparison estimating the long-term benefit of esketamine nasal spray when compared with routine treatment of treatment resistant depression …
AJ Oliveira-Maia, J Morrens, B Rive, Y Godinov, J Cabrieto, N Perualila, ...
Frontiers in Psychiatry 14, 1250980, 2023
22023
Indirect adjusted comparison of 6-month clinical outcomes between esketamine nasal spray and other real-world polypharmacy treatment strategies for treatment resistant …
AJ Oliveira-Maia, B Rive, J Morrens, Y Godinov, J Cabrieto, N Perualila, ...
Frontiers in Psychiatry 14, 1250987, 2023
12023
PMH44 Increased use of augmentation therapies illustrates complex management of treatment resistant depression. Preliminary results from a real-word evidence registry in Europe …
J Morrens, B Rive, G VanDooren, D Umuhire, S Malynn
Value in Health 22, S688, 2019
12019
Microscopische analyse van astrocyten ter hoogte van de dentate gyrus
J Morrens, W Van den Broeck
Masterproef Universiteit Gent, België, 2010
12010
Invloed van het micromilieu op de adulte neurogenese ter hoogte van de hippocampus
J MORRENS, W Van den Broeck
Masterproef faculteit diergeneeskunde, Universiteit Gent, 2008
12008
Disease severity in moderate‐to‐severe plaque psoriasis: Results from the Belgian REDISCOVER study
T Hillary, LFE Ghys, F Willaert, S Swimberghe, M Lecuyer, PD Ghislain, ...
JEADV Clinical Practice, 2023
2023
CO151 Estimating the Benefit of Esketamine Nasal Spray Versus Real-World Treatment on Patient-Reported Functional Remission: Results From the Iceberg Study
A Oliveira-Maia, B Rive, J Morrens, Y Godinov, S Mulhern-Haughey
Value in Health 25 (12), S47, 2022
2022
P. 0225 Indirect comparison estimating the benefit of esketamine compared to real-world treatment of treatment resistant depression in general psychiatry: preliminary analysis
J Morrens, AJ Oliveira-Maia, B Falissard, SM Haughey, S Barbreau, ...
European Neuropsychopharmacology 53, S162-S163, 2021
2021
P. 0226 Indirect comparison estimating the benefit of esketamine compared to distinct real-world treatment strategies for treatment resistant depression in general psychiatry
B Rive, AJ Oliveira-Maia, B Falissard, SM Haughey, S Barbreau, ...
European Neuropsychopharmacology 53, S163-S165, 2021
2021
P. 0099 Treatment resistant depression in Spain: sub-analysis from a European real-world evidence study
E Baca-García, V Pérez-Sola, PS San Miguel, J Morrens, CP Rivero, ...
European Neuropsychopharmacology 53, S71-S72, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20